{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:42:20Z","timestamp":1792395740389,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC023"],"award-info":[{"award-number":["SRC023"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcf.2026.09.014","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:51:12Z","timestamp":1792230672000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct gastrointestinal symptom phenotypes in adults with cystic fibrosis are linked to complications and medication use: the GRAMPUS-CF study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8815-8285","authenticated-orcid":false,"given":"J.","family":"Holaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-0110","authenticated-orcid":false,"given":"D.","family":"Sills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8967-2991","authenticated-orcid":false,"given":"H.","family":"Saumtally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Recto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3790-1721","authenticated-orcid":false,"given":"R.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Prayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7948-2764","authenticated-orcid":false,"given":"K.","family":"Gathercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9092-4300","authenticated-orcid":false,"given":"L.","family":"Marciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Spiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-4048","authenticated-orcid":false,"given":"C.","family":"van der Gast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-1868","authenticated-orcid":false,"given":"D.","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-2688","authenticated-orcid":false,"given":"I.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-5438","authenticated-orcid":false,"given":"A.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.09.014_bib0001","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.09.014_bib0002","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17476348.2023.2228194","article-title":"Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosis","volume":"17","author":"Yule","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2026.09.014_bib0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3310\/nihropenres.13384.1","article-title":"A grumbling concern: an international survey of gastrointestinal symptoms in cystic fibrosis in the modulator era","volume":"3","author":"Calthorpe","year":"2023","journal-title":"NIHR Open Res"},{"key":"10.1016\/j.jcf.2026.09.014_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01175-23","article-title":"Tezacaftor\/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome","volume":"11","author":"Marsh","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcf.2026.09.014_bib0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2026.09.014_bib0006","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/thorax-2023-220100","article-title":"A refresh of the top 10 research priorities in cystic fibrosis","volume":"78","author":"Rowbotham","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2026.09.014_bib0007","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","article-title":"Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule","volume":"58","author":"Gelfond","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2026.09.014_bib0008","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biocel.2014.02.005","article-title":"Cystic fibrosis: evidence for gut inflammation","volume":"52","author":"Munck","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0009","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jcf.2020.06.004","article-title":"Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging","volume":"20","author":"Ng","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00394-025-03766-y","article-title":"Interrelationships between diet quality and health-related quality of life in Irish adults living with cystic fibrosis","volume":"64","author":"Greaney","year":"2025","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jcf.2026.09.014_bib0011","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cgh.2024.05.042","article-title":"Novel irritable bowel syndrome subgroups are reproducible in the global adult population","volume":"23","author":"Black","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.14309\/ajg.0000000000000975","article-title":"A novel method to classify and subgroup patients with IBS based on gastrointestinal symptoms and psychological profiles","volume":"116","author":"Black","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0013","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0014","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3109\/00365529509101605","article-title":"Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer","volume":"30","author":"Dimen\u00e4s","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0015","doi-asserted-by":"crossref","unstructured":"Svedlund J., Sjodin I., Dotevall G. GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable Bowel Syndrome and peptic ulcer disease. vol. 33. 1988.","DOI":"10.1007\/BF01535722"},{"key":"10.1016\/j.jcf.2026.09.014_bib0016","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0017","unstructured":"Foster E., Delve J., Simpson E., Breininger S.-P. Comparison study: INTAKE24 vs Interviewer led recall final report. 2014."},{"key":"10.1016\/j.jcf.2026.09.014_bib0018","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/CCM.0000000000004710","article-title":"Practitioner\u2019s guide to Latent class analysis: methodological considerations and common pitfalls. HHS public access","volume":"49","author":"Sinha","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcf.2026.09.014_bib0019","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jcf.2021.11.014","article-title":"Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis","volume":"21","author":"Marsh","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0020","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1017\/S1368980013002115","article-title":"Designing and developing a literature-derived, population-based dietary inflammatory index","volume":"17","author":"Shivappa","year":"2014","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.jcf.2026.09.014_bib0021","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1093\/jn\/133.11.3476","article-title":"The Diet Quality Index-International (DQI-I) provides an effective tool for cross-national comparison of diet quality as illustrated by China and the United States","volume":"133","author":"Kim","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.jcf.2026.09.014_bib0022","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cgh.2022.09.019","article-title":"High-dimensional clustering of 4000 irritable bowel syndrome patients reveals seven distinct disease subsets","volume":"22","author":"Byale","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0023","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jcf.2024.02.015","article-title":"Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor\/tezacaftor\/ivacaftor","volume":"23","author":"Duong","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MOG.0000000000001151","article-title":"Pathophysiology of cystic fibrosis-related liver disease","volume":"42","author":"Palmiotti","year":"2026","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0025","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.3748\/wjg.v26.i41.6322","article-title":"Focus on gastroesophageal reflux disease in patients with cystic fibrosis","volume":"26","author":"Bongiovanni","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0026","doi-asserted-by":"crossref","unstructured":"Yibirin M., De Oliveira D., Valera R., Plitt A.E, Lutgen S. Adverse effects associated with proton pump inhibitor use 2021. https:\/\/doi.org\/10.7759\/cureus.12759.","DOI":"10.7759\/cureus.12759"},{"key":"10.1016\/j.jcf.2026.09.014_bib0027","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2026.09.014_bib0028","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/bph.12077","article-title":"The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin","volume":"168","author":"Broad","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0029","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcf.2023.10.001","article-title":"Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged \u226512 years \u2013 The RECOVER study","volume":"23","author":"Mainz","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: report of promise-GI","volume":"22","author":"Schwarzenberg","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0031","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcf.2023.08.004","article-title":"What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes (compared to recommended guidelines) in adults with cystic fibrosis\u2013A systematic review","volume":"22","author":"Greaney","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0032","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/fsn3.3914","article-title":"Association of dietary inflammatory index with constipation: evidence from the National Health and Nutrition Examination Survey","volume":"12","author":"Wang","year":"2024","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.jcf.2026.09.014_bib0033","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0095798420930932","article-title":"Latent class analysis: a guide to best practice","volume":"46","author":"Weller","year":"2020","journal-title":"J Black Psychol"},{"key":"10.1016\/j.jcf.2026.09.014_bib0034","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/2050640619841545","article-title":"A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders","volume":"7","author":"Hayee","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jcf.2026.09.014_bib0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcf.2020.12.021","article-title":"Designing the GALAXY study: partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms","volume":"20","author":"Freeman","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.014_bib0036","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2026.09.014_bib0037","series-title":"The use of magnetic resonance imaging to elucidate the mechanisms of gastrointestinal symptoms and complications in cystic fibrosis","year":"2022"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:02:28Z","timestamp":1792393348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1569199326037677"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct gastrointestinal symptom phenotypes in adults with cystic fibrosis are linked to complications and medication use: the GRAMPUS-CF study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}